560 related articles for article (PubMed ID: 18583712)
21. Suppression of VEGF-mediated autocrine and paracrine interactions between prostate cancer cells and vascular endothelial cells by soy isoflavones.
Guo Y; Wang S; Hoot DR; Clinton SK
J Nutr Biochem; 2007 Jun; 18(6):408-17. PubMed ID: 17142033
[TBL] [Abstract][Full Text] [Related]
22. Chimeric VEGFRs are activated by a small-molecule dimerizer and mediate downstream signalling cascades in endothelial cells.
Knight EL; Warner AJ; Maxwell A; Prigent SA
Oncogene; 2000 Nov; 19(47):5398-405. PubMed ID: 11103941
[TBL] [Abstract][Full Text] [Related]
23. Flt-1, but not Flk-1 mediates hyperpermeability through activation of the PI3-K/Akt pathway.
Vogel C; Bauer A; Wiesnet M; Preissner KT; Schaper W; Marti HH; Fischer S
J Cell Physiol; 2007 Jul; 212(1):236-43. PubMed ID: 17311300
[TBL] [Abstract][Full Text] [Related]
24. Shb promotes blood vessel formation in embryoid bodies by augmenting vascular endothelial growth factor receptor-2 and platelet-derived growth factor receptor-beta signaling.
Rolny C; Lu L; Agren N; Nilsson I; Roe C; Webb GC; Welsh M
Exp Cell Res; 2005 Aug; 308(2):381-93. PubMed ID: 15919073
[TBL] [Abstract][Full Text] [Related]
25. Regulation of the vascular endothelial growth factor (VEGF) receptor Flk-1/KDR by estradiol through VEGF in uterus.
Hervé MA; Meduri G; Petit FG; Domet TS; Lazennec G; Mourah S; Perrot-Applanat M
J Endocrinol; 2006 Jan; 188(1):91-9. PubMed ID: 16394178
[TBL] [Abstract][Full Text] [Related]
26. VE-cadherin increases the half-life of VEGF receptor 2.
Calera MR; Venkatakrishnan A; Kazlauskas A
Exp Cell Res; 2004 Oct; 300(1):248-56. PubMed ID: 15383331
[TBL] [Abstract][Full Text] [Related]
27. Tumor-induced activation of lymphatic endothelial cells via vascular endothelial growth factor receptor-2 is critical for prostate cancer lymphatic metastasis.
Zeng Y; Opeskin K; Goad J; Williams ED
Cancer Res; 2006 Oct; 66(19):9566-75. PubMed ID: 17018613
[TBL] [Abstract][Full Text] [Related]
28. Contact inhibition of VEGF-induced proliferation requires vascular endothelial cadherin, beta-catenin, and the phosphatase DEP-1/CD148.
Grazia Lampugnani M; Zanetti A; Corada M; Takahashi T; Balconi G; Breviario F; Orsenigo F; Cattelino A; Kemler R; Daniel TO; Dejana E
J Cell Biol; 2003 May; 161(4):793-804. PubMed ID: 12771128
[TBL] [Abstract][Full Text] [Related]
29. Fetal stromal-dependent paracrine and intracrine vascular endothelial growth factor-a/vascular endothelial growth factor receptor-1 signaling promotes proliferation and motility of human primary myeloma cells.
Vincent L; Jin DK; Karajannis MA; Shido K; Hooper AT; Rashbaum WK; Pytowski B; Wu Y; Hicklin DJ; Zhu Z; Bohlen P; Niesvizky R; Rafii S
Cancer Res; 2005 Apr; 65(8):3185-92. PubMed ID: 15833849
[TBL] [Abstract][Full Text] [Related]
30. Vascular endothelial growth factor receptor-2 and low affinity VEGF binding sites on human glomerular endothelial cells: Biological effects and advanced glycosilation end products modulation.
Pala L; Cresci B; Manuelli C; Maggi E; Yamaguchi YF; Cappugi P; Rotella CM; Giannini S
Microvasc Res; 2005 Nov; 70(3):179-88. PubMed ID: 16271941
[TBL] [Abstract][Full Text] [Related]
31. Autocrine VEGF-A system in podocytes regulates podocin and its interaction with CD2AP.
Guan F; Villegas G; Teichman J; Mundel P; Tufro A
Am J Physiol Renal Physiol; 2006 Aug; 291(2):F422-8. PubMed ID: 16597608
[TBL] [Abstract][Full Text] [Related]
32. Role of VEGF family members and receptors in coronary vessel formation.
Tomanek RJ; Holifield JS; Reiter RS; Sandra A; Lin JJ
Dev Dyn; 2002 Nov; 225(3):233-40. PubMed ID: 12412005
[TBL] [Abstract][Full Text] [Related]
33. Modulation of vascular endothelial growth factor receptors in melanocytes.
Kim EJ; Park HY; Yaar M; Gilchrest BA
Exp Dermatol; 2005 Aug; 14(8):625-33. PubMed ID: 16026585
[TBL] [Abstract][Full Text] [Related]
34. VEGF and PlGF promote adult vasculogenesis by enhancing EPC recruitment and vessel formation at the site of tumor neovascularization.
Li B; Sharpe EE; Maupin AB; Teleron AA; Pyle AL; Carmeliet P; Young PP
FASEB J; 2006 Jul; 20(9):1495-7. PubMed ID: 16754748
[TBL] [Abstract][Full Text] [Related]
35. A selective and oral small molecule inhibitor of vascular epithelial growth factor receptor (VEGFR)-2 and VEGFR-1 inhibits neovascularization and vascular permeability.
Patel N; Sun L; Moshinsky D; Chen H; Leahy KM; Le P; Moss KG; Wang X; Rice A; Tam D; Laird AD; Yu X; Zhang Q; Tang C; McMahon G; Howlett A
J Pharmacol Exp Ther; 2003 Sep; 306(3):838-45. PubMed ID: 12766257
[TBL] [Abstract][Full Text] [Related]
36. Tissue factor pathway inhibitor-2 is upregulated by vascular endothelial growth factor and suppresses growth factor-induced proliferation of endothelial cells.
Xu Z; Maiti D; Kisiel W; Duh EJ
Arterioscler Thromb Vasc Biol; 2006 Dec; 26(12):2819-25. PubMed ID: 17023682
[TBL] [Abstract][Full Text] [Related]
37. Akt is a key modulator of endothelial progenitor cell trafficking in ischemic muscle.
Hur J; Yoon CH; Lee CS; Kim TY; Oh IY; Park KW; Kim JH; Lee HS; Kang HJ; Chae IH; Oh BH; Park YB; Kim HS
Stem Cells; 2007 Jul; 25(7):1769-78. PubMed ID: 17412896
[TBL] [Abstract][Full Text] [Related]
38. [Autocrine stimulation of receptor-tyrosine kinases (RTK) in human tumor cell lines in vitro: therapeutic implications].
Gaumann A; Groot M; Drexler HC; Breier G
Verh Dtsch Ges Pathol; 2003; 87():232-9. PubMed ID: 16888917
[TBL] [Abstract][Full Text] [Related]
39. In mice with type 2 diabetes, a vascular endothelial growth factor (VEGF)-activating transcription factor modulates VEGF signaling and induces therapeutic angiogenesis after hindlimb ischemia.
Li Y; Hazarika S; Xie D; Pippen AM; Kontos CD; Annex BH
Diabetes; 2007 Mar; 56(3):656-65. PubMed ID: 17327433
[TBL] [Abstract][Full Text] [Related]
40. Autocrine vascular endothelial growth factor signalling in breast cancer. Evidence from cell lines and primary breast cancer cultures in vitro.
Weigand M; Hantel P; Kreienberg R; Waltenberger J
Angiogenesis; 2005; 8(3):197-204. PubMed ID: 16328160
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
